Symbiotec Pharmalab IPO Review
Symbiotec Pharmalab IPO Pages
π
Detailed review coming soon
Our editorial team is preparing an in-depth analysis of Symbiotec Pharmalab IPO covering company financials, valuation, strengths, risks and apply-or-skip verdict. Below is the structured information we have confirmed so far.
Price / Issue Price
βΉ988
Lot Size
15
Type
Mainboard
Exchange
BSE, NSE
Already listed.
Issued at βΉ988, listed at βΉ988
(+0.00%)
on 31 Aug 2026.
IPO Details
- Type
- Mainboard
- Country
- India